Case number 2016-1731
Braintree Labs. v. Breckenridge Pharm. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | BRAINTREE LABS. v. BRECKENRIDGE PHARM. [OPINION] [nonprecedential] (0) |
| Aug 10, 2017 | 58 | Mandate issued to the United States District Court for the Southern District of New York. Service as of this date by Clerk of Court. [452888] [SJ] [Entered: 08/10/2017 09:37 AM] (1) |
| Aug 3, 2017 | 57 | ORDER filed denying [43] petition for panel rehearing filed by Breckenridge Pharmaceutical, Inc.; denying [43] petition for en banc rehearing filed by Breckenridge Pharmaceutical, Inc. By: En Banc (Per Curiam). Service as of this date by Clerk of Court. [451317] [JAB] [Entered: 08/03/2017 03:26 PM] (2) |
| Jul 21, 2017 | 56 | 18 paper copies of the response [55] received from Appellant Braintree Laboratories, Inc. [448201] [SJ] [Entered: 07/21/2017 10:57 AM] (0) |
| Jul 19, 2017 | 55 | RESPONSE of Appellant Braintree Laboratories, Inc. to the petition for panel rehearing [43] filed by Appellee Breckenridge Pharmaceutical, Inc. in 16-1731 , petition for en banc rehearing [43] filed by Appellee Breckenridge Pharmaceutical, Inc. in 16-1731. Service: 07/19/2017 by email. [447645] [John Regan] [Entered: 07/19/2017 01:52 PM] (23) |
| Jul 5, 2017 | 54 | The court invites a response from Appellant Braintree Laboratories, Inc. to the combined petition for rehearing filed by Appellee in 16-1731. The response is due on or before July 19, 2017. [444220] [JAB] [Entered: 07/05/2017 02:35 PM] (1) |
| Jun 28, 2017 | 53 | 18 paper copies of the amicus Brief [52] received from Amicus Curiae Bernard Levin. [442772] [SJ] [Entered: 06/28/2017 11:57 AM] (0) |
| Jun 27, 2017 | 52 | AMICUS BRIEF FILED on Petition for Bernard Levin[50]. Pages: 10. The filer is directed to submit the approriate number of copies within two days, see Fed. Cir. R. 25(c). [442453] [JAB] [Entered: 06/27/2017 01:57 PM] (18) |
| Jun 27, 2017 | 51 | ORDER filed granting motion to file amicus brief on en banc or rehearing petition [47]. By: Per Curiam. Service as of this date by Clerk of Court. [442446] [JAB] [Entered: 06/27/2017 01:50 PM] (2) |
| Jun 20, 2017 | 50 | TENDERED from BERNARD LEVIN, M.D., FACP Title: AMICUS CURIAE BRIEF. Service: 06/20/2017 by email. [440693] [Thomas Parker] [Entered: 06/20/2017 10:32 AM] (18) |
| Jun 20, 2017 | 49 | NOTICE OF REJECTION: The brief of Bernard Levin, Amicus Curiae Brief [48], is not in compliance with the rules of this court and is therefore rejected for filing.. Service as of this date by Clerk of Court. [440635] [SJ] [Entered: 06/20/2017 08:57 AM] (3) |
| Jun 19, 2017 | 48 | TENDERED from Bernard Levin, MD Title: AMICUS CURIAE BRIEF. Service: 06/19/2017 by email. [440558] This brief has been rejected. See Doc. No. [49] [Thomas Parker] [Entered: 06/19/2017 06:04 PM] (0) |
| Jun 19, 2017 | 47 | MOTION of Bernard Levin, M.D. for leave to file an amicus curiae brief. Any response is due within 10 days of service, for leave to file amicus brief in support of Bernard Levin, M.D. on petition for panel rehearing [43], petition for en banc rehearing [43]. Any response is due within 10 days of service [Consent: not addressed]. Service: 06/19/2017 by email. [440555] [Thomas Parker] [Entered: 06/19/2017 05:58 PM] (7) |
| Jun 19, 2017 | 46 | Entry of appearance for Stephen Yang as of counsel for Bernard Levin, M.D. FACP. Service: 06/19/2017 by email. [440410] [Stephen Yang] [Entered: 06/19/2017 02:44 PM] (1) |
| Jun 19, 2017 | 45 | Entry of appearance for Thomas J. Parker as principal counsel for Bernard Levin, M.D., FACP. Service: 06/19/2017 by email. [440399] [Thomas Parker] [Entered: 06/19/2017 02:38 PM] (2) |
| Jun 6, 2017 | 44 | 18 paper copies of the petition for panel rehearing [43], petition for en banc rehearing [43] received from Appellee Breckenridge Pharmaceutical, Inc. [436685] [SJ] [Entered: 06/06/2017 01:07 PM] (0) |
| Jun 5, 2017 | 43 | Petition for panel rehearing, for en banc rehearing filed by Appellee Breckenridge Pharmaceutical, Inc.. Service: 06/05/2017 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 06/07/2017 [436421] [Steven Lieberman] [Entered: 06/05/2017 03:49 PM] (34) |
| May 5, 2017 | 42 | OPINION and JUDGMENT filed. The judgment or decision is: Reversed and Remanded. (Nonprecedential Opinion). (For the Court: Newman,Circuit Judge; Moore,Circuit Judge and Wallach,Circuit Judge). [429322] [CAB] [Entered: 05/05/2017 10:48 AM] (13) |
| Jan 11, 2017 | 41 | Submitted after ORAL ARGUMENT by Mark Christopher Fleming for Braintree Laboratories, Inc. and Mr. Steven M. Lieberman for Breckenridge Pharmaceutical, Inc. Panel: Judge: Newman , Judge: Moore , Judge: Wallach. [397779] [JCP] [Entered: 01/11/2017 10:47 AM] (0) |
| Dec 14, 2016 | 40 | Response to oral argument order from the Appellee Breckenridge Pharmaceutical, Inc.. designating Steven M. Lieberman as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [390849] [Steven Lieberman] [Entered: 12/14/2016 10:05 AM] (0) |
| Dec 14, 2016 | 39 | Response to oral argument order from the Appellant Braintree Laboratories, Inc.. designating Mark C. Fleming as arguing attorney. Designated time for argument: 12 minutes. Designated time for rebuttal: 3 minutes. Service of other counsel by Notice of Docket Activity from this entry. [390831] [Michael Greene] [Entered: 12/14/2016 09:37 AM] (0) |
| Nov 21, 2016 | 38 | NOTICE OF CALENDARING. Panel: 1701I. Case scheduled Jan 11, 2017 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 203. Response to oral argument order due: 12/15/2016. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [385052] THIS NOTICE APPLIES TO CASE(S): [16-1214, 16-1630, 16-1664, 16-1731] [JAB] [Entered: 11/21/2016 02:17 PM] (0) |
| Nov 15, 2016 | 37 | Notice from Appellee Breckenridge Pharmaceutical, Inc. regarding conflicts with oral argument (January 13, 2017 and March 6, 2017). Service: 11/15/2016 by email. [383334] [Steven Lieberman] [Entered: 11/15/2016 05:16 PM] (3) |
| Aug 22, 2016 | 36 | Notice from Appellant Braintree Laboratories, Inc. regarding conflicts with oral argument (October 3-7, and November 3-4). Service: 08/22/2016 by email. [360845] [John Regan] [Entered: 08/22/2016 02:19 PM] (1) |
| Aug 17, 2016 | 35 | 6 paper copies of the Joint Appendix [32] received from Appellant Braintree Laboratories, Inc. [359859] [KW] [Entered: 08/18/2016 09:52 AM] (0) |
| Aug 16, 2016 | 34 | Notice from Appellee Breckenridge Pharmaceutical, Inc. regarding conflicts with oral argument (October 3-7, 2016, November 1-4 and 7, 2016). Service: 08/16/2016 by email. [359123] [Steven Lieberman] [Entered: 08/16/2016 10:44 AM] (2) |
| Aug 16, 2016 | 33 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 08/23/2016. [359020] [JB] [Entered: 08/16/2016 08:59 AM] (0) |
| Aug 16, 2016 | 32 | APPENDIX FILED for Braintree Laboratories, Inc. [31]. Number of Pages: 369. Service: 08/15/2016 by email. Pursuant to Fed. Cir. R. 30(a)(5), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 08/22/2016. [359019] [JB] [Entered: 08/16/2016 08:58 AM] (369) |
| Aug 15, 2016 | 31 | TENDERED from Appellant Braintree Laboratories, Inc.. Title: JOINT APPENDIX. Service: 08/15/2016 by email. [358847] [John Regan] [Entered: 08/15/2016 03:03 PM] (369) |
| Aug 10, 2016 | 30 | 6 paper copies of the Reply Brief [28] received from Appellant Braintree Laboratories, Inc. [357935] [KW] [Entered: 08/11/2016 09:08 AM] (0) |
| Aug 9, 2016 | 29 | Statement of Compliance with Fed. Cir. R. 33 for Appellant Braintree Laboratories, Inc. and Appellee Breckenridge Pharmaceutical, Inc.. Service: 08/09/2016 by email. [357361] [16-1731] [John Regan] [Entered: 08/09/2016 02:19 PM] (4) |
| Aug 5, 2016 | 28 | REPLY BRIEF FILED for Appellant Braintree Laboratories, Inc. [27]. Number of Pages: 30. Service: 08/05/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 08/15/2016. Appendix is due 08/15/2016. [357207] [CAB] [Entered: 08/09/2016 10:18 AM] (40) |
| Aug 5, 2016 | 27 | TENDERED from Appellant Braintree Laboratories, Inc.. Title: REPLY BRIEF. Service: 08/05/2016 by email. [356621] [John Regan] [Entered: 08/05/2016 04:40 PM] (40) |
| Jul 8, 2016 | 26 | **TEXT ONLY** ORDER granting motion to extend time to file reply brief [25] filed by Appellant Braintree Laboratories, Inc. reply brief is due 08/05/2016. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [349485] [JB] [Entered: 07/08/2016 02:28 PM] (0) |
| Jul 8, 2016 | 25 | MOTION of Appellant Braintree Laboratories, Inc. to extend the time to 08/05/2016 at 11:59 pm to file the reply brief. Response/Opposition is due 07/21/2016 [Consent: unopposed]. Service: 07/08/2016 by email. [349383] [John Regan] [Entered: 07/08/2016 12:05 PM] (5) |
| Jul 8, 2016 | 24 | 6 paper copies of the Opening Response Brief [23] received from Appellee Breckenridge Pharmaceutical, Inc. [349271] [JCP] [Entered: 07/08/2016 09:38 AM] (0) |
| Jul 5, 2016 | 23 | BRIEF FILED for Appellee Breckenridge Pharmaceutical, Inc. [22]. Number of Pages: 61. Service: 07/05/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 07/11/2016. Appellant Braintree Laboratories, Inc. reply brief is due 07/22/2016. [348688] [JB] [Entered: 07/06/2016 11:16 AM] (72) |
| Jul 5, 2016 | 22 | TENDERED from Appellee Breckenridge Pharmaceutical, Inc.. Title: RESPONSE BRIEF. Service: 07/05/2016 by email. [348513] [Steven Lieberman] [Entered: 07/05/2016 04:30 PM] (72) |
| May 24, 2016 | 21 | 6 paper copies of the Opening Brief [20] received from Appellant Braintree Laboratories, Inc. [338661] [MJL] [Entered: 05/26/2016 10:49 AM] (0) |
| May 20, 2016 | 20 | BRIEF FILED for Appellant Braintree Laboratories, Inc. [19]. Number of Pages: 54. Service: 05/20/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 05/31/2016. Appellee Breckenridge Pharmaceutical, Inc. brief is due 07/05/2016. [337476] [JB] [Entered: 05/23/2016 11:19 AM] (100) |
| May 20, 2016 | 19 | TENDERED from Appellant Braintree Laboratories, Inc.. Title: OPENING BRIEF. Service: 05/20/2016 by email. [337252] [John Regan] [Entered: 05/20/2016 04:00 PM] (100) |
| May 5, 2016 | 18 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Breckenridge Pharmaceutical, Inc.. Service: 05/05/2016 by email. [332641] [Steven Lieberman] [Entered: 05/05/2016 05:45 PM] (5) |
| May 5, 2016 | 17 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Braintree Laboratories, Inc.. Service: 05/05/2016 by email. [332429] [John Regan] [Entered: 05/05/2016 10:21 AM] (4) |
| May 3, 2016 | 16 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a), Fed. Cir. R. 47.3 and ECF-2(E) to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [331569] [JB] [Entered: 05/03/2016 11:30 AM] (0) |
| Apr 5, 2016 | 15 | Entry of appearance for Robert F. Vroom as of counsel for Appellee Breckenridge Pharmaceutical, Inc.. Service: 04/05/2016 by email. [323875] [Robert Vroom] [Entered: 04/05/2016 08:56 AM] (2) |
| Apr 4, 2016 | 14 | Entry of appearance for Lisa N. Phillips as of counsel for Appellee Breckenridge Pharmaceutical, Inc.. Service: 04/04/2016 by email. [323804] [Lisa Phillips] [Entered: 04/04/2016 05:37 PM] (2) |
| Apr 4, 2016 | 13 | Entry of appearance for Jennifer P. Nock as of counsel for Appellee Breckenridge Pharmaceutical, Inc.. Service: 04/04/2016 by email. [323802] [Jennifer Nock] [Entered: 04/04/2016 05:18 PM] (2) |
| Apr 4, 2016 | 12 | Docketing Statement for the Appellee Breckenridge Pharmaceutical, Inc.. Service: 04/04/2016 by email. [323795] [Steven Lieberman] [Entered: 04/04/2016 05:10 PM] (4) |
| Apr 4, 2016 | 11 | Certificate of Interest for the Appellee Breckenridge Pharmaceutical, Inc.. Service: 04/04/2016 by email. [323793] [Steven Lieberman] [Entered: 04/04/2016 05:08 PM] (3) |
| Apr 4, 2016 | 10 | Entry of appearance for Steven M. Lieberman as principal counsel for Appellee Breckenridge Pharmaceutical, Inc.. Service: 04/04/2016 by email. [323792] [Steven Lieberman] [Entered: 04/04/2016 05:06 PM] (2) |
| Apr 4, 2016 | 9 | Docketing Statement for the Appellant Braintree Laboratories, Inc.. Service: 04/04/2016 by email. [323720] [John Regan] [Entered: 04/04/2016 03:42 PM] (4) |
| Apr 4, 2016 | 8 | Certificate of Interest for the Appellant Braintree Laboratories, Inc.. Service: 04/04/2016 by email. [323717] [John Regan] [Entered: 04/04/2016 03:41 PM] (2) |
| Apr 4, 2016 | 7 | Entry of appearance for Michael A. Greene as of counsel for Appellant Braintree Laboratories, Inc.. Service: 04/04/2016 by email. [323714] [Michael Greene] [Entered: 04/04/2016 03:39 PM] (2) |
| Apr 4, 2016 | 6 | Entry of appearance for Anna E. Lumelsky as of counsel for Appellant Braintree Laboratories, Inc.. Service: 04/04/2016 by email. [323712] [Anna Lumelsky] [Entered: 04/04/2016 03:38 PM] (2) |
| Apr 4, 2016 | 5 | Entry of appearance for Mark C. Fleming as of counsel for Appellant Braintree Laboratories, Inc.. Service: 04/04/2016 by email. [323710] [Mark Fleming] [Entered: 04/04/2016 03:36 PM] (2) |
| Apr 4, 2016 | 4 | Entry of appearance for Christopher R. Noyes as of counsel for Appellant Braintree Laboratories, Inc.. Service: 04/04/2016 by email. [323708] [Christopher Noyes] [Entered: 04/04/2016 03:34 PM] (2) |
| Apr 4, 2016 | 3 | Entry of appearance for John J. Regan as principal counsel for Appellant Braintree Laboratories, Inc.. Service: 04/04/2016 by email. [323706] [John Regan] [Entered: 04/04/2016 03:31 PM] (2) |
| Mar 29, 2016 | 2 | Transcript Purchase Order Form for the Appellant Braintree Laboratories, Inc. indicating that a transcript is already on file. Service: 03/29/2016 by email. [322525] [Christopher Noyes] [Entered: 03/29/2016 02:43 PM] (1) |
| Mar 21, 2016 | 1 | Appeal docketed. Received: 03/17/2016. [320203]Entry of Appearance due 04/04/2016. Certificate of Interest is due on 04/04/2016. Docketing Statement due 04/04/2016. Appellant/Petitioner's brief is due 05/20/2016. [JB] [Entered: 03/21/2016 09:14 AM] (37) |
